Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2 x 5-week Multicenter, Cross-over Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan 80 mg Compared to Irbesartan 150 mg in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

NCT00171080 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2 x 5-week Multicenter, Cross-over Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan 80 mg Compared to Irbesartan 150 mg in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
March 31, 2006
Enrollment
86 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension